171 related articles for article (PubMed ID: 32542556)
1. Tumor Regression Grade in Gastric Cancer After Preoperative Therapy.
Ikoma N; Estrella JS; Blum Murphy M; Das P; Minsky BD; Mansfield P; Ajani JA; Badgwell BD
J Gastrointest Surg; 2021 Jun; 25(6):1380-1387. PubMed ID: 32542556
[TBL] [Abstract][Full Text] [Related]
2. Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
Yin H; Yao Q; Xie Y; Niu D; Jiang W; Cao H; Feng X; Li Y; Li Y; Zhang X; Shen L; Chen Y
Cancer Med; 2023 Oct; 12(19):19633-19643. PubMed ID: 37749981
[TBL] [Abstract][Full Text] [Related]
3. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.
Ikoma N; Blum M; Estrella JS; Das P; Hofstetter WL; Fournier KF; Mansfield P; Ajani JA; Badgwell BD
Gastric Cancer; 2018 Jan; 21(1):74-83. PubMed ID: 28643144
[TBL] [Abstract][Full Text] [Related]
5. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
[TBL] [Abstract][Full Text] [Related]
6. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
8. Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer.
Stark AP; Estrella JS; Chiang YJ; Das P; Minsky BD; Blum Murphy MA; Ajani JA; Mansfield P; Badgwell BD; Ikoma N
J Surg Oncol; 2020 Sep; 122(3):422-432. PubMed ID: 32462681
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy.
Stark AP; Ikoma N; Chiang YJ; Estrella JS; Das P; Minsky BD; Blum MM; Ajani JA; Mansfield P; Badgwell BD
Ann Surg Oncol; 2019 Oct; 26(11):3602-3610. PubMed ID: 31350645
[TBL] [Abstract][Full Text] [Related]
10. Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Yun JK; Kim Y; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
Cancer Med; 2022 Oct; 11(19):3623-3632. PubMed ID: 35434935
[TBL] [Abstract][Full Text] [Related]
11. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved.
Ikoma N; Estrella JS; Hofstetter W; Das P; Minsky BD; Ajani JA; Fournier KF; Mansfield P; Badgwell BD
Ann Surg Oncol; 2018 Jul; 25(7):2012-2017. PubMed ID: 29748883
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
[TBL] [Abstract][Full Text] [Related]
13. Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer.
Sinnamon AJ; Savoldy M; Mehta R; Dineen SP; Peña LR; Lauwers GY; Pimiento JM
Ann Surg Oncol; 2023 Jun; 30(6):3580-3589. PubMed ID: 36765008
[TBL] [Abstract][Full Text] [Related]
14. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
[TBL] [Abstract][Full Text] [Related]
15. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
Rice TW; Ishwaran H; Kelsen DP; Hofstetter WL; Apperson-Hansen C; Blackstone EH;
Dis Esophagus; 2016 Nov; 29(8):906-912. PubMed ID: 27905170
[TBL] [Abstract][Full Text] [Related]
17. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
18. The ypT category does not impact overall survival in node negative gastric cancer.
Ikoma N; Hofstetter WL; Estrella JS; Das P; Minsky BD; Fournier KF; Mansfield PF; Ajani JA; Badgwell BD
J Surg Oncol; 2018 Jun; 117(8):1721-1728. PubMed ID: 29949666
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
[TBL] [Abstract][Full Text] [Related]
20. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
Noble F; Lloyd MA; Turkington R; Griffiths E; O'Donovan M; O'Neill JR; Mercer S; Parsons SL; Fitzgerald RC; Underwood TJ;
Br J Surg; 2017 Dec; 104(13):1816-1828. PubMed ID: 28944954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
